TY - JOUR
T1 - Smoking cessation counseling and treatment
T2 - An American Dental Association Clinical Evaluators Panel survey
AU - Council on Scientific Affairs
AU - Kumar, Purnima
AU - Viola, Thomas
AU - Frazier, Kevin
AU - Duong, Mai L.Y.
AU - Khajotia, Sharukh
AU - Urquhart, Olivia
N1 - Publisher Copyright:
© 2021 American Dental Association
PY - 2021/10
Y1 - 2021/10
N2 - Background: Given the oral health implications of smoking, vaping, and using smokeless tobacco products (STPs), the dental office can be an effective setting for clinicians to offer smoking cessation counseling and treatment (SCCT). Methods: A survey tool was developed to assess dentists’ approach and experience with SCCT. This survey was deployed electronically on May 21, 2021, to the American Dental Association Clinical Evaluators (ACE) Panel (N = 982), and 1 week later, nonresponders were sent reminders. Results were summarized in SAS Version 9.4. Results: Of the 283 survey responders, one-half offered SCCT to their patients. Of those who offered SCCT, 69% would be willing to prescribe pharmacologic agents to help with cessation. Nine of 10 times, SCCT conversations included the dentist. Of the 49% of respondents who did not offer SCCT, one-quarter were current or past smokers, vapers, or STP users. Out of all of the survey respondents, 40% were aware that SCCT is part of most medical benefits. Most respondents (82%) perform surgeries on patients who smoke, vape, or use STPs. Conclusions: Implementation of SCCT in the dental office was split among ACE panelists, but when it was offered, the dentist was almost always involved. Awareness about SCCT medical benefits and surgical protocols for current smokers, vapers, and STP users differed among this sample. Practical Implications: Dentists can benefit from more formal training and resources around SCCT and access to reimbursement for having these crucial conversations with their patients.
AB - Background: Given the oral health implications of smoking, vaping, and using smokeless tobacco products (STPs), the dental office can be an effective setting for clinicians to offer smoking cessation counseling and treatment (SCCT). Methods: A survey tool was developed to assess dentists’ approach and experience with SCCT. This survey was deployed electronically on May 21, 2021, to the American Dental Association Clinical Evaluators (ACE) Panel (N = 982), and 1 week later, nonresponders were sent reminders. Results were summarized in SAS Version 9.4. Results: Of the 283 survey responders, one-half offered SCCT to their patients. Of those who offered SCCT, 69% would be willing to prescribe pharmacologic agents to help with cessation. Nine of 10 times, SCCT conversations included the dentist. Of the 49% of respondents who did not offer SCCT, one-quarter were current or past smokers, vapers, or STP users. Out of all of the survey respondents, 40% were aware that SCCT is part of most medical benefits. Most respondents (82%) perform surgeries on patients who smoke, vape, or use STPs. Conclusions: Implementation of SCCT in the dental office was split among ACE panelists, but when it was offered, the dentist was almost always involved. Awareness about SCCT medical benefits and surgical protocols for current smokers, vapers, and STP users differed among this sample. Practical Implications: Dentists can benefit from more formal training and resources around SCCT and access to reimbursement for having these crucial conversations with their patients.
UR - http://www.scopus.com/inward/record.url?scp=85114904307&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114904307&partnerID=8YFLogxK
U2 - 10.1016/j.adaj.2021.07.014
DO - 10.1016/j.adaj.2021.07.014
M3 - Article
C2 - 34579811
AN - SCOPUS:85114904307
SN - 0002-8177
VL - 152
SP - 872-873.e2
JO - Journal of the American Dental Association
JF - Journal of the American Dental Association
IS - 10
ER -